Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type & Application The global ventricular assist devices market will witness a robust CAGR of 7.13%, valued at $1.39 billion in 2021, expected to appreciate and reach $2.58 billion by 2030, confirms Strategic Market Research. As a result, the global industry forecast suggests that it will reach a landmark of around USD 2.59 billion by 2030. The European Union held the highest share of the market in 2020. Ventricular assist device for adults is a mechanical pump made for people with heat-related issues to support their blood flow within the heart. ventricular assist device and cpr are the most widely used ways for cardiac arrest and reducing blood pressure. In addition, VADs can be very beneficial in diabetes, high blood pressure, lung diseases, and heart failure. Market Drivers - Rise in Technological Development, Increasing Cardiovascular Diseases, and Rise in Geriatric People The demand for a heart transplant has increased because of the increasing cardiovascular diseases and comparatively lower number of cardiac assist devices. However, this is accompanied by the shortage of decent hearts for transplantation to meet global demand. Apart from the CVDs, the rise in technological development in mechanical circulatory support has increased the demand for these devices in heart patients. Furthermore, the rising demand for the various ventricular assist devices like ventricular assist device icd 10, ventricular assist device impella, ventricular assist device ACLS, ventricular assist device anesthesia, ventricular assist device anticoagulation, ventricular assist device battery, ventricular assist device blood pressure, left ventricular assist device ICD 10, ventricular assist device BJA, ventricular assist device bradycardia, ventricular assist device cpr, ventricular assist device DRG, , ventricular assist device dementia, ventricular assist device ECMO, ventricular assist device echo, ventricular assist device defibrillators, ventricular assist device fibrillators, ventricular assist device la gi, ventricular assist device hypertrophy, 3rd generation ventricular assist device, ventricular assist device hypertension, jarvik 2015 ventricular assist device, ventricular assist device kegunaan, ventricular assist device for cad, ventricular assist device hemodynamic effect, ventricular assist device kosten, ventricular assist device flow measurement, Abiomed, HeartMate 3, HeartWare, HeartWare LVAD, etc are driving the market growth significantly. Restraints - High Cost of Left Ventricular Devices Left ventricular assist devices (LVADs) are widely used as a bridge to heart transplantation. The occurrence of LVAD related issues usually occurs in around 60% of the patients within six months from implantation and 80% of the patients within one year of implantation, which involves a much higher cost. One left ventricular assist device battery will provide 4 to 5 hours of usage. When the battery is low, it will need to be replaced again and again, which in turn is obstructing the overall market growth. Opportunities - Development and Need for Portable and Advanced Fetal Monitors This market consists of many companies in the product development phase. The companies with products in the pipeline are focusing on innovative solutions. The TAH industry is anticipating to witness a rise in approvals and launches in the upcoming years. In addition, the TAHs comes with some advanced features compared to SynCardia Total Heart, which was a sole player until December of 2020. Market Analysis Of Different Segments Covered in the Report Based on Application Bridge to transplant therapy (BTT) Destination Therapy Bridge to recovery therapy (BTR) Bridge to candidacy therapy (BTC) Based on Design Transcutaneous ventricular assist devices Implantable ventricular assist devices Based on Product Left ventricular assist devices (LVADs) Suitable ventricular assist devices (VADs) Biventricular assist devices Regional Coverage Analysis North America U.S. Canada Mexico Rest of North America Europe France Germany U.K Spain Italy Rest of Europe Asia Pacific China India Japan Australia Rest of APAC LAMEA Brazil Saudi Arabia South Africa Rest of LAMEA Segments Analysis & Insights Based on the Application, Bridge to transplant (BTT) has the largest market share due to the increasing awareness about transplantation. In addition, the availability of VADs for BTT has accounted for the growth of this segment. Based on Design, Implantable heart pump devices has the largest ventricular assist devices market share in 2020 due to the innovative product development by leading players and the increasing need for an effective solution to manage heart failure. The Defibrillator-Heart Pump is an Implantable Ventricular Assist Device with Integrated Defibrillator Component that is widely used across the globe. Fibrillation causes irregular heart rhythms, and defibrillation is regarded as the most accurate treatment for life-threatening cardiac diseases. Based on Product, Left Ventricular assist devices held the largest share and are also the fastest-growing segment in this market. This growth is because of technological advancements, increasing heart failures, and the shortage of organ donors. As a result, the LVAD market was valued at USD 357 million in 2020. Based on Regions, Europe led the indusrty in 2020 because of the increasing adoption of heart pump devices, the number of research activities for improving current technologies, and the increasing number of CVDs. Ventricular Assist Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 1.39 Billion Revenue forecast in 2030 USD 2.58 Billion Growth rate CAGR of approximately 7.13% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Application, By Design, By Product, By Region By Application Bridge to transplant therapy (BTT), Destination Therapy, Bridge to recovery therapy (BTR), Bridge to candidacy therapy (BTC). By Design Transcutaneous ventricular assist devices, Implantable ventricular assist devices. By Product Left ventricular assist devices (LVADs), Suitable ventricular assist devices (VADs), Biventricular assist devices. By Region The Middle East and Africa, North America, Latin America, Asia Pacific, Europe. Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles Abbott Laboratories, Abiomed, Teleflex Incorporated, Medtronic, SynCardia Systems, Fresenius Medical Care AG & Co. KGaA, Getinge, CardiacAssist Inc., Berlin Heart, Jarvik Heart Inc., SENKO MEDICAL INSTRUMENT Mfg. CO., LTD., CardioDyme, World Heart Corporation. Global Ventricular Assist Devices Market Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors prevailing in the worldwide market environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc. Abbott Laboratories Abiomed Medtronic Teleflex Incorporated SynCardia Systems Fresenius Medical Care AG & Co. KGaA Getinge CardiacAssist Inc. Berlin Heart Jarvik Heart Inc. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. CardioDyme World Heart Corporation Global Industry Recent Developments In June 2021, Abbott declared that they have the adequate supply and capacity to support the growing demand for mechanical circulatory support (MCS) devices to ensure the effective treatment of heart-related issues by following Medtronic's Decision to stop the distribution of HeartWave Ventricular assist device. In February 2021, FDA approved CARMAT's Early feasibility study (EFS) in the U.S. This version comes with certain improvements for the wearable and prosthesis system. The company says that they believe this latest version should improve the safety of patients and quality of life. In May 2020, FDA approved Abbott's updated labeling for the device "HeartMate3", a heart pump used by pediatric patients with advanced refractory left ventricular heart failure. Frequently Asked Question About This Report Which design segment had the highest share of the global market? Based on Design, Implantable heart pump devices had the largest market share in 2021. Who are the essential players prevailing in the global market? The most vital players in the global market are Abbott Laboratories, Abiomed Medtronic, Teleflex Incorporated, SynCardia Systems, Fresenius Medical Care AG & Co. KGaA, Getinge (Sweden), CardiacAssist Inc., Berlin Heart, Jarvik Heart Inc., SENKO MEDICAL INSTRUMENT Mfg. CO., LTD., CardioDyme, World Heart Corporation, etc. What are the most dominant regions of the global market? Based on Regions, Europe held the largest regional market share in 2021. What is the ventricular assist devices market growth? The global ventricular assist devices market is expected to grow at a compound annual growth rate (CAGR) of 7.13% from 2021 to 2030 to reach USD 2.58 Billion by 2030. How big is this ventricular assist devices market size ? The global ventricular assist devices market size was $1.39 Bn in 2021 and is predicted to reach $2.58 Bn by 2030, representing a CAGR of 7.13%. Sources https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913502/ https://www.dicardiology.com/content/fda-oks-use-new-version-carmat-artificial-heart-us-early-feasibility-study https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) https://pmc.ncbi.nlm.nih.gov/articles/PMC1360116/ https://www.cdc.gov/stroke/data-research/facts-stats/index.html https://www.bafound.org/statistics-and-facts/ https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2758472 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size By bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size By Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Ventricular Assist Devices Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Analysis 4.3.1 Global Market, By region, 2021 - 2030 (USD Million) 4.4 By Application Analysis 4.4.1 Global Market, Based on Application, 2021 - 2030 (USD Million) 4.5 By Design Analysis 4.5.1 Global Market, By Design, 2021 - 2030 (USD Million) 4.6 By Product Analysis 4.6.1 Global Market, By Product, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Collaborative Robot Manufacturing Sites, Area Served, Product Payload 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: Based on Application Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Bridge to transplant therapy (BTT) 7.3.1. Bridge to transplant therapy (BTT) market, 2021 - 2030 (USD Million) 7.4. Destination Therapy 7.4.1. Destination Therapy market, 2021 - 2030 (USD Million) 7.5. Bridge to recovery therapy (BTR) 7.5.1. Bridge to recovery therapy (BTR) market, 2021 - 2030 (USD Million) 7.6. Bridge to candidacy therapy (BTC) 7.6.1. Bridge to candidacy therapy (BTC)market, 2021 - 2030 (USD Million) 8. Global Market: By Design Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Transcutaneous ventricular assist devices 8.3.1. Transcutaneous Market, 2021 - 2030 (USD Million) 8.4. Implantable ventricular assist devices 8.4.1. Implantable Market, 2021 - 2030 (USD Million) 9. Global Market: By Product Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Left ventricular assist devices (LVADs) 9.3.1. Left ventricular assist devices (LVADs) market, 2021 - 2030 (USD Million) 9.4. Suitable ventricular assist devices (VADs) 9.4.1. Suitable ventricular assist devices (VADs) market, 2021 - 2030 (USD Million) 9.5. Biventricular assist devices 9.5.1. BiMarket, 2021 - 2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Application, 2021 - 2030 (USD Million) 10.1.2. North America Market, By Design, 2021 - 2030 (USD Million) 10.1.3. North America Market, By Product, 2021 - 2030 (USD Million) 10.1.4. North America Market, By Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Application, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By Design, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, By Product, 2021 - 2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, By Application, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By Design, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, By Product, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Application, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By Design, 2021 - 2030 (USD Million) 10.2.3. Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.4. Europe Market, By country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Application, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By Design, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, By Product, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Application, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By Design, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, By Product, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Application, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By Design, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, By Product, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Application, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By Design, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Application, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By Design, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, By country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Application, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By Design, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, By Product, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Application, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By Design, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, By Product, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Application, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, By Design, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, By Product, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Application, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By Design, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, By Product, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Application, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By Design, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, By Product, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Application, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By Design, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, By country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Application, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By Design, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, By Product, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Application, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By Design, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, By Product, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America Market, By Application, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By Design, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, By Product, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Application, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By Design, 2021 - 2030 (USD Million) 10.5.3. MEA Market, By Product, 2021 - 2030 (USD Million) 10.5.4. MEA Market, By Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Abbott Laboratories 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. ABIOMED 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. MEDTRONIC 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. TELEFLEX INCORPORATED 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. SYNCARDIA SYSTEMS 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Fresenius Medical Care AG & Co. KGaA 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Getinge 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. CardiacAssist Inc 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Berlin Heart 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Jarvik Heart Inc 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. CardioDyme. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. World Heart Corporation 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development List of Tables (57 Tables) TABLE 1. Market, Based on Application, 2021-2030 (USD Million) TABLE 2. Market FOR Bridge to transplant therapy (BTT), BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Destination Therapy, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Bridge to recovery therapy (BTR), BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Bridge to candidacy therapy (BTC), BY REGION, 2021-2030 (USD Million) TABLE 6. Market, By Design, 2021-2030 (USD Million) TABLE 7. Market FOR Transcutaneous ventricular assist devices, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Implantable ventricular assist devices, BY REGION, 2021-2030 (USD Million) TABLE 9. Market, BY PRODUCT, 2021-2030 (USD Million) TABLE 10. Market FOR Left ventricular assist devices (LVADs), BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Suitable ventricular assist devices (VADs), BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Biventricular assist devices, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Battery Powered Collaborative Robot, BY REGION, 2021-2030 (USD Million) TABLE 15. Market, BY REGION, 2021-2030 (USD Million) TABLE 16. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA Market, Based on Application, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA Market, By Design, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA Market, BY PRODUCT, 2021-2030 (USD Million) TABLE 20. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. EUROPE Market, Based on Application, 2021-2030 (USD Million) TABLE 22. EUROPE Market, By Design, 2021-2030 (USD Million) TABLE 23. EUROPE Market, BY PRODUCT, 2021-2030 (USD Million) TABLE 24. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC Market, Based on Application, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC Market, By Design, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC Market, BY PRODUCT, 2021-2030 (USD Million) TABLE 28. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. LAMEA Market, Based on Application, 2021-2030 (USD Million) TABLE 30. LAMEA Market, By Design, 2021-2030 (USD Million) TABLE 31. LAMEA Market, BY PRODUCT, 2021-2030 (USD Million) TABLE 32. Abbott Laboratories: COMPANY SNAPSHOT TABLE 33. Abbott Laboratories: OPERATING SEGMENTS TABLE 34. ABIOMED: COMPANY SNAPSHOT TABLE 35. ABIOMED: OPERATING SEGMENTS TABLE 36. MEDTRONIC: COMPANY SNAPSHOT TABLE 37. MEDTRONIC: OPERATING SEGMENTS TABLE 38. TELEFLEX INCORPORATED : COMPANY SNAPSHOT TABLE 39. TELEFLEX INCORPORATED : OPERATING SEGMENTS TABLE 40. SYNCARDIA SYSTEMS: COMPANY SNAPSHOT TABLE 41. SYNCARDIA SYSTEMS: OPERATING SEGMENTS TABLE 42. Fresenius Medical Care AG & Co. KGaA: COMPANY SNAPSHOT TABLE 43. Fresenius Medical Care AG & Co. KGaA: OPERATING SEGMENTS TABLE 44. Getinge: COMPANY SNAPSHOT TABLE 45. Getinge: OPERATING SEGMENTS TABLE 46. CardiacAssist Inc: COMPANY SNAPSHOT TABLE 47. CardiacAssist Inc: OPERATING SEGMENTS TABLE 48. Berlin Heart: COMPANY SNAPSHOT TABLE 49. Berlin Heart: OPERATING SEGMENTS TABLE 50. Jarvik Heart Inc: COMPANY SNAPSHOT TABLE 51. Jarvik Heart Inc: OPERATING SEGMENTS TABLE 52. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.: COMPANY SNAPSHOT TABLE 53. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.: OPERATING SEGMENTS TABLE 54. CardioDyme: COMPANY SNAPSHOT TABLE 55. CardioDyme: OPERATING SEGMENTS TABLE 56. World Heart Corporation: COMPANY SNAPSHOT TABLE 57. World Heart Corporation: OPERATING SEGMENTS List of Figures (19 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Market, By Design, 2019 vs. 2025 (USD Million) Figure 9 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 10 Market Share, Based on Application, 2019 vs. 2025 (USD Million) Figure 11 Geographical Snapshot of the Market Figure 12 Bridge to transplant (BTT) to Witness Higher CAGR in Market for, Based on Application during Forecast Period. Figure 13 Implantable heart pump devices to Witness Higher CAGR in Market Based on Design. Figure 14 Left Ventricular assist devices to Witness Higher CAGR in Market Based on Product. Figure 15 Europe region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges Figure 17 North America: Market Snapshot Figure 18 Asia Pacific: Market Snapshot Figure 19 Vendor Dive: Evaluation Overview